Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial.
Horn A, Wendel J, Franke I, Bauer A, Baumeister H, Bendig E, Brucker SY, Deutsch TM, Garatva P, Haas K, Heil L, Hügen K, Manger H, Pryss R, Rücker V, Salmen J, Szczesny A, Vogel C, Wallwiener M, Wöckel A, Heuschmann PU; BETTER-CARE Study Group. Horn A, et al. Trials. 2024 Nov 14;25(1):767. doi: 10.1186/s13063-024-08614-8. Trials. 2024. PMID: 39543763 Free PMC article.
Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma.
Dickerson LK, Lehnert AL, Hamlin DK, Labadie KP, Goodsell KE, Liu Y, Li Y, Wilbur DS, Miyaoka R, Park JO. Dickerson LK, et al. Among authors: lehnert al. Res Sq [Preprint]. 2024 Jun 27:rs.3.rs-4456645. doi: 10.21203/rs.3.rs-4456645/v1. Res Sq. 2024. Update in: EJNMMI Res. 2024 Aug 22;14(1):74. doi: 10.1186/s13550-024-01134-1 PMID: 38978570 Free PMC article. Updated. Preprint.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Innovations in Small-Animal PET Instrumentation.
Lehnert AL, Miyaoka RS. Lehnert AL, et al. PET Clin. 2024 Jan;19(1):59-67. doi: 10.1016/j.cpet.2023.09.002. Epub 2023 Sep 27. PET Clin. 2024. PMID: 37775371 Review.
Effects of intermittent fasting on quality of life tolerance of chemotherapy in patients with gynecological cancers: study protocol of a randomized-controlled multi-center trial.
Schmidt MW, Brenner W, Gebhard S, Schmidt M, Singer S, Weidenbach L, Hahn H, Puzankova D, Blau-Schneider B, Lehnert A, Battista MJ, Almstedt K, Lütkemeyer A, Radsak MP, Mähringer-Kunz A, Krajnak S, Linz VC, Schwab R, Gabriel B, Hasenburg A, Anic K. Schmidt MW, et al. Among authors: lehnert a. Front Oncol. 2023 Jul 19;13:1222573. doi: 10.3389/fonc.2023.1222573. eCollection 2023. Front Oncol. 2023. PMID: 37538111 Free PMC article.
75 results